BRUSSELS (Reuters) - Belgian biotech company TiGenix said on Tuesday it was in advanced discussions to sell its Dutch manufacturing facility and separately to find a partner for its candidate treatment for a disorder linked to Crohn's disease.

via Reuters: Health News Read More Here..
No comments:
Post a Comment